| Methods |
Prospective randomised comparative study. No further details |
| Participants |
200 women with singleton pregnancy, 28 to 40 weeks' gestation with PIH. |
| Interventions |
Exp: oral labetalol. No dose specified. Number of women not specified.
Control: oral methyldopa. No dose specified. Number of women not specified. |
| Outcomes |
BP, control of proteinuria, mode of delivery, neonatal Apgar score, NICU admission, neonatal complications, perinatal deaths. |
| Notes |
Available as abstract only. Not possible to extract data. |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Random sequence generation (selection bias) |
Unclear risk |
Not described |
| Allocation concealment (selection bias) |
Unclear risk |
Not described |
| Blinding of participants and personnel (performance bias)
All outcomes |
Unclear risk |
Not described |
| Blinding of outcome assessment (detection bias)
All outcomes |
Unclear risk |
Not described |
| Incomplete outcome data (attrition bias)
All outcomes |
Unclear risk |
Not described |
| Selective reporting (reporting bias) |
Unclear risk |
Not described |
| Other bias |
Unclear risk |
Funding source and declaration of interests not described |
